{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:27Z","timestamp":1787020827654,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"health department of the navarre government","award":["project 007-2017"],"award-info":[{"award-number":["project 007-2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inherited muscle diseases are a group of rare heterogeneous muscle conditions with great impact on quality of life, for which variable prevalence has previously been reported, probably due to case selection bias. The aim of this study is to estimate the overall and selective prevalence rates of inherited muscle diseases in a northern Spanish region and to describe their demographic and genetic features. Retrospective identification of patients with inherited muscle diseases between 2000 and 2015 from multiple data sources. Demographic and molecular data were registered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      On January 1, 2016, the overall prevalence of inherited muscle diseases was 59.00\/ 100,000 inhabitants (CI 95%; 53.35\u201365.26). Prevalence was significantly greater in men (67.33\/100,000) in comparison to women (50.80\/100,000) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006). The highest value was seen in the age range between 45 and 54 (91.32\/100,000) years. Myotonic dystrophy type 1 was the most common condition (35.90\/100,000), followed by facioscapulohumeral muscular dystrophy (5.15\/100,000) and limb-girdle muscular dystrophy type 2A (2.5\/100,000).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prevalence of inherited muscle diseases in Navarre is high in comparison with the data reported for other geographical regions. Standard procedures and analyses of multiple data sources are needed for epidemiological studies of this heterogeneous group of diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-019-1227-x","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:09:09Z","timestamp":1575281349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region"],"prefix":"10.1186","volume":"14","author":[{"given":"Inmaculada","family":"Pagola-Lorz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Torn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsaso","family":"Elizalde-Beiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Garcia-Solaesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu","family":"Delfrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-6370","authenticated-orcid":false,"given":"Ivonne","family":"Jeric\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"1227_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","volume":"381","author":"E Mercuri","year":"2013","unstructured":"Mercuri E, Muntoni F. Muscular dystrophies. Lancet. 2013;381:845\u201360.","journal-title":"Lancet."},{"key":"1227_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0960-8966(02)00155-4","volume":"13","author":"MG D\u2019Angelo","year":"2003","unstructured":"D\u2019Angelo MG, Bresolin N. Report of the 95th European neuromuscular Centre (ENMC) sponsored international workshop cognitive impairment in neuromuscular disorders, Naarden, the Netherlands, 13-15 July 2001. Neuromuscul Disord. 2003;13:72\u20139.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/16501970600731578","volume":"38","author":"F Boyer","year":"2006","unstructured":"Boyer F, Drame M, Morrone I, Novella J-L. Factors relating to carer burden for families of persons with muscular dystrophy. J Rehabil Med. 2006;38:309\u201315.","journal-title":"J Rehabil Med"},{"key":"1227_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/WNL.0000000000003504","volume":"88","author":"S Lefter","year":"2017","unstructured":"Lefter S, Hardiman O, Ryan AM. A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland. Neurology. 2017;88:304\u201313.","journal-title":"Neurology."},{"key":"1227_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000494115","volume":"52","author":"A Theadom","year":"2019","unstructured":"Theadom A, Rodrigues M, Poke G, O\u2019Grady G, Love D, Hammond-Tooke G, et al. A Nationwide, population-based prevalence study of genetic muscle disorders. Neuroepidemiology. 2019;52:128\u201335.","journal-title":"Neuroepidemiology"},{"key":"1227_CR6","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awp236","volume":"132","author":"FLM Norwood","year":"2009","unstructured":"Norwood FLM, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132:3175\u201386.","journal-title":"Brain"},{"key":"1227_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0960-8966(94)00017-4","volume":"6","author":"MI Hughes","year":"1996","unstructured":"Hughes MI, Hicks EM, Nevin NCPV. The prevalence of inherited neuromuscular disease in Northern Ireland. Neuromuscul Disord. 1996;6:69\u201373.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000110107","volume":"6","author":"S Araki","year":"1987","unstructured":"Araki S, Uchino M, Kumamoto T. Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district. Japan Neuroepidemiology. 1987;6:120\u20139.","journal-title":"Japan Neuroepidemiology"},{"key":"1227_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-8966(99)00055-3","volume":"10","author":"N Darin","year":"2000","unstructured":"Darin N, Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord. 2000;10:1\u20139.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/08830738030180030201","volume":"18","author":"B Chung","year":"2003","unstructured":"Chung B, Wong V, Ip P. Prevalence of neuromuscular diseases in Chinese children: a study in southern China. J Child Neurol. 2003;18:217\u20139.","journal-title":"J Child Neurol"},{"key":"1227_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000088674","volume":"25","author":"HN El-Tallawy","year":"2005","unstructured":"El-Tallawy HN, Khedr EM, Qayed MH, Helliwell TR, Kamel NF. Epidemiological study of muscular disorders in Assiut. Egypt Neuroepidemiology. 2005;25:205\u201311.","journal-title":"Egypt Neuroepidemiology"},{"issue":"3","key":"1227_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1399-0004.1988.tb02854.x","volume":"34","author":"SE Tangsrud","year":"1988","unstructured":"Tangsrud SE, Halvorsen S. Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to \"non-Duchenne muscular dystrophy\". Clin Genet. 1988;34(3):145\u201352.","journal-title":"Clin Genet"},{"key":"1227_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ana.410160302","volume":"16","author":"JF Kurtzke","year":"1984","unstructured":"Kurtzke JF. Neuroepidemiology. Ann Neurol. 1984;16:265\u201377.","journal-title":"Ann Neurol"},{"key":"1227_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000110327","volume":"12","author":"G Ahlstr\u00f6m","year":"1993","unstructured":"Ahlstr\u00f6m G, Gunnarsson LG, Leissner P, Sj\u00f6d\u00e9n PO. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology. 1993;12:262\u20139.","journal-title":"Neuroepidemiology."},{"key":"1227_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000369343","volume":"43","author":"A Theadom","year":"2014","unstructured":"Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, et al. Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 2014;43:259\u201368.","journal-title":"Neuroepidemiology."},{"key":"1227_CR16","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1212\/WNL.43.8.1573","volume":"43","author":"A L\u00f3pez de Munain","year":"1993","unstructured":"L\u00f3pez de Munain A, Blanco A, Emparanza JI, Poza JJ, Mart\u00ed Mass\u00f3 JF, Cobo A, et al. Prevalence of myotonic dystrophy in Guip\u00fazcoa (Basque Country, Spain). Neurology. 1993;43:1573\u20136.","journal-title":"Neurology"},{"key":"1227_CR17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1093\/brain\/121.9.1735","volume":"121","author":"M Urtasun","year":"1998","unstructured":"Urtasun M, S\u00e1enz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM, et al. Limb-girdle muscular dystrophy in Guip\u00fazcoa (Basque Country, Spain). Brain. 1998;121:1735\u201347.","journal-title":"Brain"},{"key":"1227_CR18","first-page":"61","volume":"7","author":"J Burcet","year":"1992","unstructured":"Burcet J, Ca\u00f1ellas F, Cavaller G, Vich M. Epidemiologic study of myotonic dystrophy on the island of Mallorca. Neurologia. 1992;7:61\u20134.","journal-title":"Neurologia."},{"key":"1227_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/mus.10507","volume":"28","author":"J Arpa","year":"2003","unstructured":"Arpa J, Cruz-Mart\u00ednez A, Campos Y, Guti\u00e9rrez-Molina M, Garc\u00eda-Rio F, P\u00e9rez-Conde C, et al. Prevalence and progression of mitochondrial diseases: a study of 50 patients. Muscle Nerve. 2003;28:690\u20135.","journal-title":"Muscle Nerve"},{"key":"1227_CR20","unstructured":"Statistics Navarre 2016 Census. https:\/\/administracionelectronica.navarra.es\/GN.InstitutoEstadistica.Web\/informacionestadistica.aspx?R=1&E=1. Accessed 1 Jun 2018."},{"key":"1227_CR21","unstructured":"Ministerio de Sanidad y Consumo. Encuesta Nacional de Salud 2011\u20132012. https:\/\/www.navarra.es\/home_es\/Temas\/Portal+de+la+Salud\/Profesionales\/Informacion+tecnica\/Sanidad\/encuesta+de+salud.htm. Accessed 1 Jun 2018."},{"key":"1227_CR22","volume-title":"Zonificaci\u00f3n Navarra","author":"European data portal","year":"2000","unstructured":"European data portal. Zonificaci\u00f3n Navarra. 2000 https:\/\/www.europeandataportal.eu\/data\/en\/dataset\/spasitnaestadi_pol_szonnav2000-xml01. Accessed 1 Jun 2018."},{"key":"1227_CR23","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.nmd.2017.10.005","volume":"27","author":"G Bonne","year":"2017","unstructured":"Bonne G, Rivier F, Hamroun D. The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscul Disord. 2017;27:1152\u201383.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR24","doi-asserted-by":"crossref","unstructured":"Harris E, Laval S, Hudson J, Barresi R, De Waele L, Straub V, et al. Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysis. PLoS Curr. 2013;5.","DOI":"10.1371\/currents.md.37f840ca67f5e722945ecf755f40487e"},{"key":"1227_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nmd.2013.12.011","volume":"24","author":"CG B\u00f6nnemann","year":"2014","unstructured":"B\u00f6nnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24:289\u2013311.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR26","first-page":"13","volume":"10","author":"B McARDLE","year":"1951","unstructured":"McARDLE B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci. 1951;10:13\u201335.","journal-title":"Clin Sci"},{"key":"1227_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","volume":"18","author":"H Jungbluth","year":"2011","unstructured":"Jungbluth H, Sewry CA, Muntoni F. Core myopathies. Semin Pediatr Neurol. 2011;18:239\u201349.","journal-title":"Semin Pediatr Neurol"},{"key":"1227_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1750-3639.2001.tb00393.x","volume":"11","author":"A Bornemann","year":"2001","unstructured":"Bornemann A, Goebel HH. Congenital myopathies. Brain Pathol. 2001;11:206\u201317.","journal-title":"Brain Pathol"},{"key":"1227_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ana.10693","volume":"54","author":"H Tajsharghi","year":"2003","unstructured":"Tajsharghi H, Thornell L-E, Lindberg C, Lindvall B, Henriksson K-G, Oldfors A. Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann Neurol. 2003;54:494\u2013500.","journal-title":"Ann Neurol"},{"key":"1227_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.spen.2011.10.004","volume":"18","author":"C Wallgren-Pettersson","year":"2011","unstructured":"Wallgren-Pettersson C, Sewry CA, Nowak KJ, Laing NG. Nemaline myopathies. Semin Pediatr Neurol. 2011;18:230\u20138.","journal-title":"Semin Pediatr Neurol"},{"key":"1227_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jnen\/62.10.977","volume":"62","author":"NF Clarke","year":"2003","unstructured":"Clarke NF, North KN. Congenital fiber type disproportion--30 years on. J Neuropathol Exp Neurol. 2003;62:977\u201389.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1227_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11910-013-0434-4","volume":"14","author":"B Udd","year":"2014","unstructured":"Udd B. Distal myopathies. Curr Neurol Neurosci Rep. 2014;14:434.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5999","key":"1227_CR33","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1189044","volume":"329","author":"RJ Lemmers","year":"2010","unstructured":"Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Cama\u00f1o P, Dauwerse JG, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 2010;329(5999):1650\u20133.","journal-title":"Science"},{"key":"1227_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejim.2016.06.038","volume":"34","author":"P Fern\u00e1ndez-Navarro","year":"2016","unstructured":"Fern\u00e1ndez-Navarro P, L\u00f3pez-Abente G, Salido-Campos C, Sanz-Anquela JM. The minimum basic data set (MBDS) as a tool for cancer epidemiological surveillance. Eur J Intern Med. 2016;34:94\u20137.","journal-title":"Eur J Intern Med"},{"key":"1227_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/fampra\/cmp062","volume":"26","author":"MD Esteban-Vasallo","year":"2009","unstructured":"Esteban-Vasallo MD, Dom\u00ednguez-Berj\u00f3n MF, Astray-Mochales J, G\u00e8nova-Maleras R, P\u00e9rez-Sania A, S\u00e1nchez-Perruca L, et al. Epidemiological usefulness of population-based electronic clinical records in primary care: estimation of the prevalence of chronic diseases. Fam Pract. 2009;26:445\u201354.","journal-title":"Fam Pract"},{"key":"1227_CR36","unstructured":"Anc\u00edn Ducay J, Erce L\u00f3pez S, Extramiana Cameno E, Izcue Argando\u00f1a A. Correlaci\u00f3n de c\u00f3digos CEI-9-MC (8a edic) - CIAP-2 para la gesti\u00f3n de Incapacidad Teporal. Inst Salud P\u00fablica y Labor Navarra. 2014; https:\/\/www.navarra.es\/NR\/rdonlyres\/E520399C-0612-4C75-A912-B16295014FC3\/281429\/codigosCIE_9_MC.pdf. Accessed 1 Jun 2018."},{"key":"1227_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ejmg.2018.03.008","volume":"61","author":"A Kinsner-Ovaskainen","year":"2018","unstructured":"Kinsner-Ovaskainen A, Lanzoni M, Garne E, Loane M, Morris J, Neville A, et al. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU platform on rare diseases registration. Eur J Med Genet. 2018;61:513\u20137.","journal-title":"Eur J Med Genet"},{"key":"1227_CR38","first-page":"e1","volume":"90","author":"Y Florist\u00e1n Florist\u00e1n","year":"2016","unstructured":"Florist\u00e1n Florist\u00e1n Y, Delfrade Osinaga J, Carrillo Prieto J, Aguirre Perez J, Moreno-Iribas C. Coding causes of death with IRIS software. Impact in Navarre mortality statistic. Rev Esp Salud Publica. 2016;90:e1\u20139.","journal-title":"Rev Esp Salud Publica"},{"key":"1227_CR39","volume-title":"About Spain data on causes of death","author":"R G\u00f3mez-Redondo","year":"2017","unstructured":"G\u00f3mez-Redondo R, Faus-Bertomeu A, Poniakina S, C\u00e1mara-Izquierdo N. About Spain data on causes of death. 2017. https:\/\/www.causesofdeath.org\/Data\/ESP\/20170126\/ESP_bd.pdf. Accessed 1 Jun 2018."},{"key":"1227_CR40","unstructured":"Estad\u00edsticas epidemiol\u00f3gicas de c\u00f3digo abierto para Salud P\u00fablica. Versi\u00f3n 3.01. http:\/\/www.openepi.com\/Menu\/OE_Menu.htm. Accessed 1 Jun 2018."},{"key":"1227_CR41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/jmg.22.4.250","volume":"22","author":"JR Yates","year":"1985","unstructured":"Yates JR, Emery AE. A population study of adult onset limb-girdle muscular dystrophy. J Med Genet. 1985;22:250\u20137.","journal-title":"J Med Genet"},{"key":"1227_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0960-8966(92)90006-R","volume":"2","author":"L Merlini","year":"1992","unstructured":"Merlini L, Stagni SB, Marri E, Granata C. Epidemiology of neuromuscular disorders in the under-20 population in Bologna Province. Italy Neuromuscul Disord. 1992;2:197\u2013200.","journal-title":"Italy Neuromuscul Disord"},{"key":"1227_CR43","first-page":"494","volume":"84","author":"R Ballo","year":"1994","unstructured":"Ballo R, Viljoen D, Beighton P. Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected. S Afr Med J. 1994;84:494\u20137.","journal-title":"S Afr Med J"},{"key":"1227_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery AE. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991;1:19\u201329.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR45","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.nmd.2012.05.017","volume":"22","author":"J Mathieu","year":"2012","unstructured":"Mathieu J, Pr\u00e9vost C. Epidemiological surveillance of myotonic dystrophy type 1: a 25-year population-based study. Neuromuscul Disord. 2012;22:974\u20139.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/brain\/119.1.295","volume":"119","author":"M Fardeau","year":"1996","unstructured":"Fardeau M, Hillaire D, Mignard C, Feingold N, Feingold J, Mignard D, et al. Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain. 1996;119:295\u2013308.","journal-title":"Brain"},{"key":"1227_CR47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014;24:482\u201391.","journal-title":"Neuromuscul Disord"},{"key":"1227_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1034\/j.1399-0004.1999.560107.x","volume":"56","author":"G Siciliano","year":"1999","unstructured":"Siciliano G, Tessa A, Renna M, Manca ML, Mancuso M, Murri L. Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. Clin Genet. 1999;56:51\u20138.","journal-title":"Clin Genet"},{"issue":"3","key":"1227_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251\u201367.","journal-title":"Lancet Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1227-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T19:55:05Z","timestamp":1606766105000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1227-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1227"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1227-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Navarre Ethical Committee for Medical Research (Pyto 2016\/31).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}